Reclast 5mg/100ml IV Infusion Solution Premix from Canada
Reclast is a ready-to-use 5mg zoledronic acid solution in 100ml bottle for once-yearly intravenous infusion in osteoporosis and Paget's disease treatment. Classified under HTS 3004.90.92.75 due to its zoledronic acid content in measured dose retail packing for prophylactic bone therapy. It qualifies as a mixed product (with excipients) for therapeutic uses.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Maintain 2-8°C refrigeration throughout import process with validated temperature logs; include Certificate of Analysis confirming zoledronic acid potency and sterility; watch for EU/US formulation differences triggering additional bioequivalence reviews